Skip to main content

Peer Review reports

From: Safety of the first dose of fingolimod for multiple sclerosis: results of an open-label clinical trial

Original Submission
23 Dec 2013 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
11 Feb 2014 Reviewed Reviewer Report - Pasquale Annunziata
13 Feb 2014 Reviewed Reviewer Report - Tomas Uher
10 Mar 2014 Author responded Author comments - Giovanni Mancardi
Resubmission - Version 3
10 Mar 2014 Submitted Manuscript version 3
Publishing
13 Mar 2014 Editorially accepted
1 Apr 2014 Article published 10.1186/1471-2377-14-65

You can find further information about peer review here.

Back to article page